President-elect Trump affirms support for PBM reform
With the growing demand for PBM reform, Trump has stated that action must be taken.
Pharmacy
Pharmacy organizations rally behind PBM reform legislation
Pharmacy leaders demand Congress address PBM practices.
Walgreens testifies on PBM practices and pharmacy sustainability
Walgreens joined independent pharmacies at Monday’s Arkansas Insurance and Commerce Senate hearing.
NACDS to Capitol Hill: Stand strong on PBM reform
NACDS: “As the continuing resolution is finalized, Americans and their pharmacies are watching and waiting for real PBM reform now to lower drug costs and to protect pharmacy access”.
Walgreens rolls out first Patient Advisory Board to advance access and representation in clinical research
The Walgreens Patient Advisory Board will work with the Walgreens Clinical Trials team to provide insights aimed at increasing representation in clinical trials.
Joint op-ed by National Association of Manufacturers and NACDS calls for PBM reform now
Entitled “Congress, Don’t Waste the Work Done for PBM Reform,” the piece urges the enactment of PBM reforms in Medicare and Medicaid this year.
Walgreens study: Almost a third of Americans worry about missing a holiday event due to illness
Survey shows almost half of Americans missed a holiday event in the past because of illness and are taking preventative measures to not let it happen again.
Vizient’s 2025 Trends Report gives a strategy and investment roadmap for health care leaders
Pharmacy innovation, advanced analytics and AI will drive success in the coming year.
Azar to be keynote speaker at AAM Annual Meeting
The gathering is set for the Ritz-Carlton on Amelia Island, Fla. from Feb. 3-5.
NACDS responds to HHS extending “PREP Act” for pharmacy access
The move by HHS will help maintain continuity of patients’ access to pharmacies as states continue to achieve strong progress in enhancing their policies.
NACDS, NCPA to the U.S. Congress: Stand strong and enact PBM reforms this year in Medicare and Medicaid
“We also laud the commitment of other Republican and Democratic members of the House of Representatives and of the Senate who are working hard to deliver comprehensive PBM reform before year’s end."
NPC announces Takeda’s Jen Norton as board chair for 2025
NPC’s board also elected its Executive Committee for 2025.
Deloitte 2025 Life Sciences Outlook forecasts optimism
Pricing and access to drugs and medical devices seen as the most significant issue facing the life sciences industry.
Ohio Supreme Court favors CVS, Walgreens and Walmart in national opioid case
The Ohio Supreme Court held on a 5-2 vote that state law barred Lake and Trumbull counties' claims that pharmacy chains' dispensing of addictive pain medications created a public nuisance that the companies should be forced to remediate.
Medicare plans continue trend of restricting generic drugs
A recent analysis reveals that Medicare Part D plans increasingly restrict generic drugs to higher-cost tiers.
Bask Health: Pioneering telehealth and transforming access to GLP-1 medications
Bask Health's telehealth platform seamlessly connects patients to licensed providers specializing in GLP-1 medications like semaglutide and liraglutide.
